Pacira BioSciences
$13.85
16
-$0.83-5.65% Friday 20:00
Statistik
Harga Tertinggi Hari Ini
14.9
Harga Terendah Hari Ini
13.77
52M Tinggi
35.95
52M Rendah
11.16
Volume
825,443
Rata-Rata Volume
1,364,014
Kap Pasar
717.73M
Rasio P/E
11.61
Hasil Dividen
-
Dividen
-
Mendatang
Pendapatan
31OctDiharapkan
EPS yang Diharapkan
0.724889
EPS Aktual
T/A
Orang Juga Mengikuti
Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti PCRX. Ini bukan rekomendasi investasi.
Peserta
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Johnson & Johnson
JNJ
Kap Pasar399.26B
Abbvie
ABBV
Kap Pasar346.75B
Teva- Pharmaceutical Industries
TEVA
Kap Pasar21.38B
AMGEN
AMGN
Kap Pasar179.38B
Merck
MRK
Kap Pasar300.25B
Novartis
NVS
Kap Pasar244.75B
Bristol-Myers Squibb
BMY
Kap Pasar101.27B
Peringkat Analis
24.63$Rata-Rata Target Harga
Perkiraan tertinggi adalah $42.
Dari 8 peringkat dalam 6 bulan terakhir. Ini bukan rekomendasi investasi.
Beli
50%
Tahan
25%
Jual
25%
Tentang
Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Show more...
CEO
David M. Stack
Karyawan
711
Negara
US
ISIN
US6951271005